News Focus
News Focus
Followers 13
Posts 566
Boards Moderated 0
Alias Born 01/20/2014

Re: Winechemist post# 395140

Tuesday, 02/06/2024 11:05:19 AM

Tuesday, February 06, 2024 11:05:19 AM

Post# of 445625
Good morning Winechemist. Your comment regarding Vyvanse totally makes sense. I'm excited about Generic Oxycontin too. I just hope after that approval they also chase SequestOx or the patented version of ADT Oxy without Naltrexone which is 90% cheaper to produce, I'm refer to below comment from Nasrat.


“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “

Thanks again Winechemist for your insight Much appreciated
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News